Substance Abuse Treatment Market Research Report by Substance Abuse Type, Product, Treatment Option, Distribution Channel, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, High Inflation

Description

List of Tables

The Global Substance Abuse Treatment Market size was estimated at USD 6,432.51 million in 2022 and expected to reach USD 7,044.96 million in 2023, projecting growth at a CAGR of 9.95% to reach USD 13,743.20 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Substance Abuse Treatment Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people's lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Substance Abuse Treatment Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Substance Abuse Treatment Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Substance Abuse Treatment Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the Global Substance Abuse Treatment Market in order to forecast the revenues and analyze the trends in each of the following sub-markets.

Based on Substance Abuse Type, the market is studied across Alcohol Addiction, Cocaine, Marijuana, and Nicotine Addiction.

Based on Product, the market is studied across Behavioral Treatment and Drugs. The Drugs is further studied across Acamprosate, Buprenorphine, Bupropion, Disulfiram, Methadone, Naltrexone, and Varenicline.

Based on Treatment Option, the market is studied across Group Counseling, In-patient Treatment, Individualized Drug Counseling, Long-Term Residential Treatment, Outpatient Treatment Programs, and Short-Term Residential Treatment.

Based on Distribution Channel, the market is studied across Hospital Pharmacies and Retail Pharmacies & Drug Stores.

Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Substance Abuse Treatment Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Substance Abuse Treatment Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Substance Abuse Treatment Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Substance Abuse Treatment Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor's strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Substance Abuse Treatment Market, including AbbVie Inc., Accord Healthcare Limited, Alkermes PLC, Amphastar Pharmaceuticals, Inc., BioCorRx, Inc., Cipla Limited, Dr. Reddy's Laboratories Ltd., Elite Pharmaceuticals, Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Indivior, LFB Group, Mallinckrodt LLC, Novartis International AG, Pfizer Inc., Purdue Pharma L.P., Reckitt Benckiser Group PLC, Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Substance Abuse Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Substance Abuse Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Substance Abuse Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Substance Abuse Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Substance Abuse Treatment Market?

6. What is the market share of the leading vendors in the Global Substance Abuse Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Substance Abuse Treatment Market?

Product Code: MRR-0376B2CAB003

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing cases of tobacco addiction across the globe
  - 5.1.1.2. Increasing patient awareness and higher treatment seeking rate
  - 5.1.1.3. Favorable efforts from the governments to curb the use of these substances
- 5.1.2. Restraints
  - 5.1.2.1. Relatively high cost of the treatment and poor treatment compliance
- 5.1.3. Opportunities
  - 5.1.3.1. Emerging number of treatment centers with partnerships with private recovery facilities
  - 5.1.3.2. Growing introduction of new products and therapy coupled with better reimbursement options
- 5.1.4. Challenges
  - 5.1.4.1. Increasing cases of discontinuation of behavioral therapies and patients opt for outpatient care
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Threat of Substitutes
- 5.5.4. Threat of Substitutes
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Substance Abuse Treatment Market, by Substance Abuse Type

6.1. Introduction
6.2. Alcohol Addiction
6.3. Cocaine
6.4. Marijuana
6.5. Nicotine Addiction

7. Substance Abuse Treatment Market, by Product

7.1. Introduction
7.2. Behavioral Treatment
7.3. Drugs
- 7.4.1. Acamprosate
- 7.4.2. Buprenorphine
- 7.4.3. Bupropion
- 7.4.4. Disulfiram
- 7.4.5. Methadone
- 7.4.6. Naltrexone
- 7.4.7. Varenicline

8. Substance Abuse Treatment Market, by Treatment Option

8.1. Introduction
8.2. Group Counseling
8.3. In-patient Treatment
8.4. Individualized Drug Counseling
8.5. Long-Term Residential Treatment
8.6. Outpatient Treatment Programs
8.7. Short-Term Residential Treatment

9. Substance Abuse Treatment Market, by Distribution Channel

9.1. Introduction
9.2. Hospital Pharmacies
9.3. Retail Pharmacies & Drug Stores

10. Americas Substance Abuse Treatment Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Substance Abuse Treatment Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Substance Abuse Treatment Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
- 13.1.1. Quadrants
- 13.1.2. Business Strategy
- 13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Product Portfolio Analysis, By Key Player
13.5. Competitive Scenario
- 13.5.1. Merger & Acquisition
- 13.5.2. Agreement, Collaboration, & Partnership
- 13.5.3. New Product Launch & Enhancement
- 13.5.4. Investment & Funding
- 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

14.1. AbbVie Inc.
14.2. Accord Healthcare Limited
14.3. Alkermes PLC
14.4. Amphastar Pharmaceuticals, Inc.
14.5. BioCorRx, Inc.
14.6. Cipla Limited
14.7. Dr. Reddy's Laboratories Ltd.
14.8. Elite Pharmaceuticals, Inc.
14.9. GlaxoSmithKline PLC
14.10. Glenmark Pharmaceuticals Limited
14.11. Indivior
14.12. LFB Group
14.13. Mallinckrodt LLC
14.14. Novartis International AG
14.15. Pfizer Inc.
14.16. Purdue Pharma L.P.
14.17. Reckitt Benckiser Group PLC
14.18. Sanofi S.A.
14.19. Teva Pharmaceutical Industries Ltd.
14.20. Viatris Inc.

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing